Press Release Bluestar Genomics Presents Data on New Applications of its Epigenomic Cancer Detection Platform ClearNote Health September 12, 2022
Press Release Bluestar Genomics Receives CLIA Certification for its Clinical Laboratory ClearNote Health June 6, 2022
Press Release Bluestar Genomics to Participate in the Goldman Sachs 2022 Healthcare Disruption Conference ClearNote Health March 30, 2022
Press Release Bluestar Genomics Presents Positive Results of its Pancreatic Cancer Test Performance Evaluation at 2022 ASCO GI Cancers Symposium ClearNote Health January 20, 2022
Press Release Bluestar Genomics Appoints David Mullarkey Chief Executive Officer ClearNote Health January 10, 2022
Press Release Bluestar Genomics Announces Plans to Present at the 40th Annual J.P. Morgan Healthcare Conference January 12 at 4:30 p.m. Eastern Time ClearNote Health January 6, 2022
Press Release Bluestar Genomics Presents New Data Showing Its Liquid Biopsy Test Detects Pancreatic Cancer Signal ClearNote Health November 5, 2021
Press Release Bluestar Genomics Closes $70M Series C Funding, Expands Scientific Advisory Board ClearNote Health May 12, 2021
Press Release Bluestar Genomics Receives FDA Breakthrough Device Designation for First-of-Its-Kind Pancreatic Cancer Screening Test ClearNote Health March 31, 2021
Press Release Bluestar Genomics’ Breakthrough Study Highlights Promising Data for Multi-Cancer Detection From a Single Blood Draw ClearNote Health January 29, 2020
